Global Esketamine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Esketamine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Esketamine is a medication used as a general anesthetic and for treatment-resistant depression.
Esketamine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Esketamine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from General Anesthetic and Treatment-resistant Depression are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Esketamine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Esketamine key manufacturers include Merck, Medkoo, Endo International, Janssen Pharmaceutica and PFIZER, etc. Merck, Medkoo, Endo International are top 3 players and held % sales share in total in 2022.
Esketamine can be divided into Oral Medications, Injection and Nasal Spray,, etc. Oral Medications is the mainstream product in the market, accounting for % sales share globally in 2022.
Esketamine is widely used in various fields, such as General Anesthetic and Treatment-resistant Depression, etc. General Anesthetic provides greatest supports to the Esketamine industry development. In 2022, global % sales of Esketamine went into General Anesthetic filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Esketamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck
Medkoo
Endo International
Janssen Pharmaceutica
PFIZER
Segment by Type
Oral Medications
Injection
Nasal Spray
General Anesthetic
Treatment-resistant Depression
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Esketamine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Esketamine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Esketamine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Esketamine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Esketamine introduction, etc. Esketamine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Esketamine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Esketamine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Esketamine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from General Anesthetic and Treatment-resistant Depression are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Esketamine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Esketamine key manufacturers include Merck, Medkoo, Endo International, Janssen Pharmaceutica and PFIZER, etc. Merck, Medkoo, Endo International are top 3 players and held % sales share in total in 2022.
Esketamine can be divided into Oral Medications, Injection and Nasal Spray,, etc. Oral Medications is the mainstream product in the market, accounting for % sales share globally in 2022.
Esketamine is widely used in various fields, such as General Anesthetic and Treatment-resistant Depression, etc. General Anesthetic provides greatest supports to the Esketamine industry development. In 2022, global % sales of Esketamine went into General Anesthetic filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Esketamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Medkoo
Endo International
Janssen Pharmaceutica
PFIZER
Segment by Type
Oral Medications
Injection
Nasal Spray
Segment by Application
General Anesthetic
Treatment-resistant Depression
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Esketamine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Esketamine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Esketamine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Esketamine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Esketamine introduction, etc. Esketamine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Esketamine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.